Osprey Pharmaceuticals Limited Announces Issuance of 3 U.S. Patents
Patents Broadly Protect Core Technology Behind Chemokine-based Therapeutic Platform
19-Apr-2007 -
Osprey Pharmaceuticals Limited, a privately held biotechnology company focused on treating chronic diseases through a family of first-in-class therapeutic proteins, announced that it has been granted three patents by the U.S. Patent Office. The patents protect the use of conjugated chemokines to ...
acids
biotechnology
chemokines
+5